See more : Aurion Resources Ltd. (AIRRF) Income Statement Analysis – Financial Results
Complete financial analysis of HEXO Corp. (HEXO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of HEXO Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Strategic Realty Trust, Inc. (SGIC) Income Statement Analysis – Financial Results
- IDW Media Holdings, Inc. (IDW) Income Statement Analysis – Financial Results
- ShineMore Technology Materials Co., Ltd. (8291.TWO) Income Statement Analysis – Financial Results
- Drillcon AB (publ) (DRIL.ST) Income Statement Analysis – Financial Results
- Velodyne Lidar, Inc. (VLDR) Income Statement Analysis – Financial Results
HEXO Corp. (HEXO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.hexocorp.com
About HEXO Corp.
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. HEXO Corp. has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 191.10M | 123.77M | 80.78M | 47.54M | 4.93M | 4.10M | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 266.78M | 74.97M | 138.76M | 20.62M | -1.47M | -2.35M | 0.00 | 0.00 | 0.00 |
| Gross Profit | -75.67M | 48.80M | -57.98M | 26.93M | 6.40M | 6.45M | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | -39.60% | 39.43% | -71.77% | 56.64% | 129.72% | 157.39% | 0.00% | 0.00% | 0.00% |
| Research & Development | 3.22M | 3.84M | 4.64M | 2.82M | 0.00 | 86.38K | 0.00 | 0.00 | 0.00 |
| General & Administrative | 99.31M | 69.92M | 78.58M | 73.96M | 14.37M | 4.27M | 0.00 | 29.29K | 29.29K |
| Selling & Marketing | 22.93M | 10.35M | 12.47M | 31.19M | 8.34M | 2.99M | 0.00 | 0.00 | 0.00 |
| SG&A | 122.24M | 80.27M | 91.06M | 105.15M | 22.71M | 7.25M | 0.00 | 29.29K | 29.29K |
| Other Expenses | 28.78M | 8.15M | 322.88M | 3.51M | 1.66M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 154.24M | 92.25M | 418.58M | 111.48M | 24.37M | 7.93M | 0.00 | 29.29K | 29.29K |
| Cost & Expenses | 421.01M | 167.22M | 557.34M | 132.10M | 22.90M | 5.58M | 0.00 | 29.29K | 29.29K |
| Interest Income | 1.65M | 1.60M | 1.90M | 5.19M | 2.12M | 92.16K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 20.07M | 32.12M | 10.04M | 469.00K | 1.53M | 522.62K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 810.10M | 16.73M | 68.25M | 5.85M | 1.66M | 591.65K | 22.82K | 0.00 | 0.00 |
| EBITDA | -257.63M | -26.73M | -476.55M | -78.70M | -14.19M | -1.75M | 0.00 | -29.29K | -29.29K |
| EBITDA Ratio | -134.81% | -21.59% | -589.91% | -165.55% | -287.60% | -42.73% | 0.00% | 0.00% | 0.00% |
| Operating Income | -1.07B | -43.45M | -476.55M | -84.56M | -17.97M | -1.48M | 0.00 | -29.29K | -29.29K |
| Operating Income Ratio | -558.72% | -35.11% | -589.91% | -177.86% | -364.14% | -36.21% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -691.53M | -71.71M | -75.96M | -847.00K | -5.38M | -10.93M | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -1.11B | -115.16M | -552.51M | -85.40M | -23.35M | -12.42M | 0.00 | -29.29K | -29.29K |
| Income Before Tax Ratio | -582.11% | -93.04% | -683.94% | -179.64% | -473.25% | -303.10% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -38.81M | -397.00K | -6.02M | -3.84M | 1.53M | 522.62K | 0.00 | 0.00 | 0.00 |
| Net Income | -1.07B | -114.76M | -546.49M | -81.56M | -23.35M | -12.42M | 0.00 | -29.29K | -29.29K |
| Net Income Ratio | -561.80% | -92.72% | -676.48% | -171.57% | -473.25% | -303.10% | 0.00% | 0.00% | 0.00% |
| EPS | -38.68 | -12.62 | -63.43 | -21.47 | -9.75 | -11.88 | 0.00 | -0.92 | 0.00 |
| EPS Diluted | -38.68 | -12.62 | -63.43 | -21.47 | -9.75 | -11.88 | 0.00 | -0.92 | 0.00 |
| Weighted Avg Shares Out | 27.76M | 9.09M | 8.62M | 3.80M | 2.40M | 1.05M | 31.54M | 31.75K | 6.22M |
| Weighted Avg Shares Out (Dil) | 27.76M | 9.09M | 8.62M | 3.80M | 2.40M | 1.05M | 31.54M | 31.75K | 6.22M |
Cannabis stocks struggle as Canada marks five years of legal recreational use
Tuesday, October 17, 2023 marks five years since recreational cannabis was legalized in Canada and it's been tough going for operators in the budding sector. Industry players have had to contend with oversaturation, competition from the black market, limited opportunities...
Investing In Top Marijuana Stocks 2023
Investing in marijuana stocks can offer a number of benefits even in a volatile market. Here are a few potential upsides to consider:
As Tilray buys Hexo, former exec sees more consolidation ahead in Canadian cannabis
Canada continues to face an oversupply of cannabis that has pushed down prices even as the cost of capital has increased, which will result in more consolidation ahead, one executive told MarketWatch on Friday.
The Growth And Future Potential Of The Cannabis Industry
Over the past few years, the cannabis industry has experienced tremendous growth. Much of which is showing no signs of slowing down anytime soon. The industry has grown from being a niche market to a multi-billion dollar industry, with legal...
HEXO Corp. Announces Completion of Acquisition by Way of Arrangement With Tilray Brands, Inc.
GATINEAU, Québec--(BUSINESS WIRE)--HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) (“HEXO” or the “Company”) announced today the closing of the second of two tranches of the non-brokered private placement of Series 1 Preferred Shares (the “Private Placement”) previously announced on June 1,...
HEXO Corp. Announces Receipt of Final Order for Arrangement With Tilray Brands, Inc.
GATINEAU, Québec--(BUSINESS WIRE)--HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) (“HEXO” or the “Company”) announced today that the Ontario Superior Court of Justice (Commercial List) (the “Court”) has granted the final order (the “Final Order”) in connection with the previously announced statutory...
HEXO Corp. (HEXO) Q3 2023 Earnings Call Transcript
HEXO Corp. (NASDAQ:HEXO ) Q3 2023 Earnings Call Transcript June 15, 2023 10:00 AM ET Company Participants Charlie Bowman - President and Chief Executive Officer Julius Ivancsits - Chief Financial Officer Conference Call Participants Matt Bottomley - Canaccord Genuity Operator...
Tilray takeover target Hexo posts decline in third-quarter financials
Hexo Corporation (NYSE:HEXO), the producer of high-quality cannabis products which has agreed to a takeover by Tilray Brands Inc (NASDAQ:TLRY), has reported a decline in net revenues and an adjusted EBITDA loss for the third quarter of its 2023 fiscal year....
HEXO (HEXO) Reports Q3 Loss, Lags Revenue Estimates
HEXO (HEXO) came out with a quarterly loss of $0.70 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $1.40 per share a year ago.
HEXO Reports Q3'23 Financial Results
GATINEAU, Québec--(BUSINESS WIRE)--HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the “Company"), a leading producer of high-quality cannabis products, today reported its financial results for the third quarter of the 2023 fiscal year (“Q3'23”). All currency amounts are stated in...
Source: https://incomestatements.info
Category: Stock Reports